![Once-Daily Dosing of Delayed-Release Oral Mesalamine (400-mg Tablet) Is as Effective as Twice-Daily Dosing for Maintenance of Remission of Ulcerative Colitis - ScienceDirect Once-Daily Dosing of Delayed-Release Oral Mesalamine (400-mg Tablet) Is as Effective as Twice-Daily Dosing for Maintenance of Remission of Ulcerative Colitis - ScienceDirect](https://ars.els-cdn.com/content/image/1-s2.0-S0016508510000065-gr1.jpg)
Once-Daily Dosing of Delayed-Release Oral Mesalamine (400-mg Tablet) Is as Effective as Twice-Daily Dosing for Maintenance of Remission of Ulcerative Colitis - ScienceDirect
![Randomised trial of once- or twice-daily MMX mesalazine for maintenance of remission in ulcerative colitis | Gut Randomised trial of once- or twice-daily MMX mesalazine for maintenance of remission in ulcerative colitis | Gut](https://gut.bmj.com/content/gutjnl/57/7/893/F2.large.jpg)
Randomised trial of once- or twice-daily MMX mesalazine for maintenance of remission in ulcerative colitis | Gut
![JCM | Free Full-Text | Switching between Three Types of Mesalazine Formulation and Sulfasalazine in Patients with Active Ulcerative Colitis Who Have Already Received High-Dose Treatment with These Agents JCM | Free Full-Text | Switching between Three Types of Mesalazine Formulation and Sulfasalazine in Patients with Active Ulcerative Colitis Who Have Already Received High-Dose Treatment with These Agents](https://www.mdpi.com/jcm/jcm-08-02109/article_deploy/html/images/jcm-08-02109-g001.png)
JCM | Free Full-Text | Switching between Three Types of Mesalazine Formulation and Sulfasalazine in Patients with Active Ulcerative Colitis Who Have Already Received High-Dose Treatment with These Agents
![PDF] Switching between Three Types of Mesalazine Formulation and Sulfasalazine in Patients with Active Ulcerative Colitis Who Have Already Received High-Dose Treatment with These Agents | Semantic Scholar PDF] Switching between Three Types of Mesalazine Formulation and Sulfasalazine in Patients with Active Ulcerative Colitis Who Have Already Received High-Dose Treatment with These Agents | Semantic Scholar](https://d3i71xaburhd42.cloudfront.net/311d68d3e2646f720d017249ff9d986a83d59097/5-Table1-1.png)
PDF] Switching between Three Types of Mesalazine Formulation and Sulfasalazine in Patients with Active Ulcerative Colitis Who Have Already Received High-Dose Treatment with These Agents | Semantic Scholar
![PDF] SPECTROPHOTOMETRIC DETERMINATION OF MESALAZINE IN BULK AND TABLET DOSAGE FORMS BASED ON DIAZOCOUPLING REACTION WITH RESORCINOL | Semantic Scholar PDF] SPECTROPHOTOMETRIC DETERMINATION OF MESALAZINE IN BULK AND TABLET DOSAGE FORMS BASED ON DIAZOCOUPLING REACTION WITH RESORCINOL | Semantic Scholar](https://d3i71xaburhd42.cloudfront.net/f6441d9ae3ad08d7f9d1ed072a951eb284a9f5a7/4-Table3-1.png)
PDF] SPECTROPHOTOMETRIC DETERMINATION OF MESALAZINE IN BULK AND TABLET DOSAGE FORMS BASED ON DIAZOCOUPLING REACTION WITH RESORCINOL | Semantic Scholar
![JCM | Free Full-Text | Switching between Three Types of Mesalazine Formulation and Sulfasalazine in Patients with Active Ulcerative Colitis Who Have Already Received High-Dose Treatment with These Agents JCM | Free Full-Text | Switching between Three Types of Mesalazine Formulation and Sulfasalazine in Patients with Active Ulcerative Colitis Who Have Already Received High-Dose Treatment with These Agents](https://www.mdpi.com/jcm/jcm-08-02109/article_deploy/html/images/jcm-08-02109-g001-550.jpg)